Christianson Gary

Insider CIK 1418881 · ONTY Chief Operating Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	8,334	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	164,500	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	15,000	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	11,300	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	68,000	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	51,200	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	41,667	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	41,667	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	16,667	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	25,000	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	8,334	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	D To issuer deriv	2018-03-09	2018-03-13	8,334	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	U Tender	2018-03-09	2018-03-13	6,515	—	$0	0	SEC↗
CASC Cascadian Therapeutics, In	A Award deriv	2018-02-01	2018-02-02	164,500	—	$0	164,500	SEC↗
CASC Cascadian Therapeutics, In	M Exercise deriv	2018-01-11	2018-01-16	2,825	—	$0	8,475	SEC↗
CASC Cascadian Therapeutics, In	F Tax w/h	2018-01-11	2018-01-16	923	$3.92	$3.6K	6,515	SEC↗
CASC Cascadian Therapeutics, In	M Exercise	2018-01-11	2018-01-16	2,825	—	$0	7,438	SEC↗
CASC Cascadian Therapeutics, In	A Award deriv	2017-09-18	2017-09-20	15,000	—	$0	15,000	SEC↗
CASC Cascadian Therapeutics, In	A Award deriv	2017-09-18	2017-09-20	68,000	—	$0	68,000	SEC↗
CASC Cascadian Therapeutics, In	A Award deriv	2017-01-11	2017-01-13	11,300	—	$0	11,300	SEC↗
CASC Cascadian Therapeutics, In	A Award deriv	2017-01-11	2017-01-13	51,200	—	$0	51,200	SEC↗
ONTY Oncothyreon Inc.	A Award deriv	2016-05-17	2016-05-19	250,000	—	$0	250,000	SEC↗
ONTY Oncothyreon Inc.	A Award deriv	2015-09-24	2015-09-28	250,000	—	$0	250,000	SEC↗
ONTY Oncothyreon Inc.	A Award deriv	2014-12-16	2014-12-16	100,000	—	$0	100,000	SEC↗
ONTY Oncothyreon Inc.	A Award deriv	2013-12-12	2013-12-16	150,000	—	$0	150,000	SEC↗
ONTY Oncothyreon Inc.	A Award deriv	2012-12-12	2012-12-14	50,000	—	$0	50,000	SEC↗